Fluconazole and Alogliptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluconazole (fluconazole) and Alogliptin (alogliptin benzoate). Common drug interactions include chronic kidney disease among females and application site haematoma among males.

The phase IV clinical study analyzes what interactions people have when they take Fluconazole and Alogliptin. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Fluconazole?

Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 70,481 Fluconazole users. Check the latest studies of Fluconazole.

What is Alogliptin?

Alogliptin has active ingredients of alogliptin benzoate. eHealthMe is studying from 1,943 Alogliptin users. Check the latest studies of Alogliptin.



On Jul, 17, 2026

45 people who take Fluconazole and Alogliptin together, and have interactions are studied.

Fluconazole and Alogliptin drug interactions.

What are the common drug interactions of Fluconazole and Alogliptin, by gender? *:

female:

  1. Chronic kidney disease
  2. Anaemia (lack of blood)
  3. Renal failure (kidney dysfunction)
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Cardiac arrest
  7. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  8. Gingivitis (inflammation of gums)
  9. Loose tooth
  10. Nephropathy (damage to or disease of a kidney)

male:

  1. Application site haematoma (collection of blood outside the blood vessels at application site)
  2. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  3. Bone loss
  4. Cardiac failure acute
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Cerebral infarction (less blood supply to brain resulting tissue damage)
  7. Constipation
  8. Coronavirus test positive
  9. Decreased appetite
  10. Depression

What are the common drug interactions of Fluconazole and Alogliptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain upper
  2. Asthma
  3. Urinary tract disorder

50-59:

  1. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  2. Chronic kidney disease
  3. Anaemia (lack of blood)
  4. Renal failure (kidney dysfunction)
  5. Cardiac arrest
  6. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  7. Nausea (feeling of having an urge to vomit)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Nephropathy (damage to or disease of a kidney)

60+:

  1. Application site haematoma (collection of blood outside the blood vessels at application site)
  2. Fatigue (feeling of tiredness)
  3. Chronic kidney disease
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Haematoma (collection of blood outside the blood vessels)
  7. Headache (pain in head)
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Influenza like illness
  10. Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 10 people, 22.22%
  2. Diabetes: 10 people, 22.22%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 17.78%
  4. High Blood Pressure: 8 people, 17.78%
  5. Pain In Extremity: 7 people, 15.56%
  6. Pulmonary Embolism (blockage of the main artery of the lung): 6 people, 13.33%
  7. Anaemia (lack of blood): 5 people, 11.11%
  8. Cardiac Disorder: 5 people, 11.11%
  9. Itching: 5 people, 11.11%
  10. Asthma: 5 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Fluconazole and Alogliptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fluconazole and Alogliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fluconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alogliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alogliptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluconazole and alogliptin benzoate (the active ingredients of Fluconazole and Alogliptin, respectively), and Fluconazole and Alogliptin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: